Michael Clancy
Partner Michael Clancy focuses on EU competition law, including advising clients on antitrust and cartel investigations, distribution, R&D collaborations, patent and trademark licensing and other commercial agreements, the clearance of mergers and joint ventures, and abuse of dominance issues. Michael has significant experience in the life sciences (pharmaceuticals, biotech, and medical devices), cosmetics, and software & technology sectors. His notable experience includes successfully defending clients in antitrust investigations by the European Commission in both the pharmaceutical and cosmetics sectors, his ongoing work on the appeal against the Commission's first decision on reverse-payment patent settlements in the pharma industry, as well as his ongoing work defending clients in the Commission’s auto-parts investigation. Michael also has in-depth experience advising a range of clients on their distribution, licensing, and other collaboration agreements. · Van Bael & Bellis
About
Partner at Van Bael & Bellis specializing in EU competition law, advising on antitrust and cartel investigations, distribution and licensing agreements, R&D collaborations, merger clearances, and abuse of dominance. He has significant experience in the life sciences, cosmetics and software & technology sectors and has defended clients in European Commission investigations (including pharmaceuticals, cosmetics and auto-parts) and is involved in the appeal against the Commission’s decision on reverse‑payment patent settlements.
Practice areas
Office
Expertise
Education
- Yale Law School – J.D., 2003
- University of Dayton – B.A. in Mechanical Engineering, 2000
Admissions
- State Bar of New York, USA
- Associate Member of the Brussels Bar